Although it has been reported that CD8+ T-cells are required for neovascularization after ischemic injury in normoglycemic patients 4, we hypothesized that too many CD8+ T-cells such as in the case of T2D could be detrimental to EC function and survival. Here, CD8A is linked to type 2 diabetes mellitus.